FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/01/039100 [Registered on: 03/01/2022] Trial Registered Prospectively
Last Modified On: 29/12/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Study of effectiveness of dexmedetomidine, when added to bupivacaine in spinal anaesthesia for lower limb surgery  
Scientific Title of Study   Effect of intrathecal Dexmedetomidine as an adjuvant to hyperbaric bupivacaine in orthopaedic lower limb surgery: An Intervention Study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Neelam Golia 
Designation  3rd Year Resident in Anaesthesiology 
Affiliation  Dr S.N. Medical College, Jodhpur 
Address  Department of Anaesthesiology, Dr S.N.Medical College and attached hospitals,Jodhpur Rajasthan 342003 India

Jodhpur
RAJASTHAN
342003
India 
Phone  8764346240  
Fax    
Email  drneelam016@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Fateh Singh Bhati 
Designation  Senior Professor in Department of Anaesthesiology 
Affiliation  Dr S.N.Medical College,Jodhpur 
Address  Department of Anaesthesiology, Mahatma Gandhi hospital, Dr S.N.Medical College,Jodhpur Rajasthan 342003 India

Jodhpur
RAJASTHAN
342003
India 
Phone  9414127176  
Fax    
Email  fatehbhati68@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Fateh Singh Bhati 
Designation  Senior Professor in Department of Anaesthesiology 
Affiliation  Dr S.N.Medical College,Jodhpur 
Address  Department of Anaesthesiology, Mahatma Gandhi Hospital, Dr S.N.Medical College, Jodhpur Rajasthan 342003 India

Jodhpur
RAJASTHAN
342003
India 
Phone  9414127176  
Fax    
Email  fatehbhati68@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology, Dr S.N.Medical College,Jodhpur 342003,Rajasthan,India 
 
Primary Sponsor  
Name  Department of Anaesthesiology 
Address  Dr S.N.Medical College,Jodhpur 342003,Rajasthan,India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Neelam Golia  Department of Anaesthesiology  Dr S.N. Medical College,Jodhpur 342003,Rajasthan India
Jodhpur
RAJASTHAN 
8764346240

drneelam016@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, Dr S.N. Medical College, Jodhpur 342003,Rajasthan,India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  control  2.5ml bupivacaine 0.5% heavy with 0.5ml normal saline,single dose 
Intervention  dexmedetomidine  5 mcg added to 2.5ml bupivacaine 0.5% heavy,single dose 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Age 18 to 65 years
2.Both genders
3.ASA grade I and II
 
 
ExclusionCriteria 
Details  1.History of spine surgery, hepatic failure, neuromuscular disorders 2.chronic history of headache, backache and infection in back 3.Any absolute or relative contraindication to study drug
4.Uncooperative patients 5.Coagulopathy 6.Patient with history of cardiac or respiratory diseases 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
motor block regression in bromage score,sensory block regression by pin prick sensation  6 to 8 hours after intrathecal injection 
 
Secondary Outcome  
Outcome  TimePoints 
Onset of Sensory and motor block, Hemodynamic alterations,
Numeric Rating Scale 6 hours after surgery. 
0 min,5 min,10 min,15 min,
20 min,25 min,30 min,45 min,
60 min,75 min,90 min,105 min,
120 min,240 min,360 min. 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   07/01/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Dexmedetomidine is an alpha-2 adrenergic receptor agonist recently introduced in indian market.
It has been used as an adjunct to spinal and general anaesthesia and for sedation in intensive care unit.
   
The aim of present study is to evaluate the efficacy of dexmedetomidine as an adjunct to bupivacaine in subarachnoid block.

Study will be carried out in 50 ASA physical status I and II, aged 18 to 65 years going to undergo lower limb orthopaedic surgery. Patients will be randomly allocated into 2 groups, each of 25 by computer generated random number table. 1st group will be given bupivacaine and 2nd group will be given bupivacaine + dexmedetomidine in subarachnoid space. Patients will be assessed for onset and duration of sensory and motor block produced by both groups.
Analgesia, hemodynamic variables and complications will be recorded intraoperatively. Patients will be observed for 6 hours postoperatively. Data will be expressed as mean and standard deviation or numbers and percentages as 
applicable. Comparison between two groups will be done using unpaired t test for quantitative data and chi square test for qualitative data. p value <0.05 will be considered significant.  
 
Close